The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments

Fondazione Italiana Linfomi (Onlus)

Research output: Contribution to journalArticlepeer-review

Abstract

The International Prognostic Score (IPS) is the most commonly used risk stratification tool for patients with advanced Hodgkin lymphoma (HL). It incorporates seven clinical parameters independently associated with a poorer outcome: male sex, age, stage IV, hemoglobin level, white blood cell and lymphocyte counts, and albumin level. Since the development of the IPS, there have been significant advances in therapy and supportive care. Recent studies suggest that the IPS is less discriminating due to improved outcomes with ABVD therapy. The aim of the present study was to asses if classic prognostic factors maintain their prognostic meaning at the time of response-adapted treatment based on interim PET scans. We evaluated the prognostic significance of IPS in the 520 advanced stage HL patients enrolled in the PET-guided, HD0801 trial in which PET2-positive patients underwent a more intense treatment with an early stem-cell transplantation after 2 cycles of ABVD. We observed that in these patients, the IPS completely loses its prognostic value together with all the single parameters that contribute to the IPS. Furthermore, neutrophils, monocytes, lymphocytes, and the ratio among them also no longer had any predictive value. We believe that the substantial improvement in survival outcomes in PET2-positive patients treated with early autologous transplantation could explain the complete disappearance of the residual prognostic significance of the IPS.

Original languageEnglish
Pages (from-to)277-282
Number of pages6
JournalAnnals of Hematology
Volume99
Issue number2
DOIs
Publication statusPublished - Feb 2020

Keywords

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols/administration & dosage
  • Autografts
  • Bleomycin/administration & dosage
  • Dacarbazine/administration & dosage
  • Disease-Free Survival
  • Doxorubicin/administration & dosage
  • Female
  • Hodgkin Disease/diagnostic imaging
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Positron-Emission Tomography
  • Stem Cell Transplantation
  • Survival Rate
  • Vinblastine/administration & dosage

Fingerprint Dive into the research topics of 'The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments'. Together they form a unique fingerprint.

Cite this